½ÃÀ庸°í¼­
»óǰÄÚµå
1507814

¼¼°èÀÇ Æ®¸³½Å ½ÃÀå : ±Ô¸ðº°, °ø±Þ¿øº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Trypsin Market Size study, By Source, By Application, By End-use, and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Æ®¸³½Å ½ÃÀåÀº 2023³â¿¡ ¾à 9,160¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ µ¿¾È 4.92% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Æ®¸³½ÅÀº ÃéÀå¿¡¼­ »ý»êµÇ´Â ¼ÒÈ­ È¿¼Ò·Î ¼ÒÀå¿¡¼­ ´Ü¹éÁúÀ» ÀÛÀº ÆéŸÀ̵å·Î ºÐÇØÇÕ´Ï´Ù. ºÒȰ¼º Àü±¸Ã¼ Æ®¸³½Ã³ë°ÕÀ¸·Î ºÐºñµÇ°í Àå ÆéÆ¼´Ù¾ÆÁ¦¿¡ ÀÇÇØ Ȱ¼ºÈ­µË´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒÈ­È¿¼Ò´Â ¿µ¾ç¼ÒÀÇ Èí¼ö¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ´Ù¸¥ ¼ÒÈ­È¿¼Ò¸¦ ºÒȰ¼ºÇü¿¡¼­ Ȱ¼ºÇüÀ¸·Î º¯È¯ÇÏ¿© Á¶ÀýÇÏ¿© È¿À²ÀûÀÎ ¼ÒÈ­¸¦ º¸ÀåÇÕ´Ï´Ù. °Ô´Ù°¡ ÷´Ü Ä¡·áÁ¦¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ¼¼°è Æ®¸³½Å ½ÃÀå¿¡¼­ ÁÖ¸ñÀ» ¹Þ°í ÀÖ½À´Ï´Ù. Æ®¸³½ÅÀº ¼¼Æ÷ ¹è¾ç °úÁ¤¿¡¼­ ¹è¾ç ¿ë±âÀÇ Ç¥¸é¿¡¼­ Á¢Âø ¼¼Æ÷¸¦ ÇØ¸®½ÃŰ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ °øÁ¤Àº ¹é½ÅÀ̳ª Ä¡·á¿ë ´Ü¹éÁúÀÇ »ý»ê¿¡ »ç¿ëµÇ´Â ¼¼Æ÷ÁÖ¸¦ À¯Áö,È®´ëÇÏ´Â ºÎºÐ ¹è¾ç¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¼¼Æ÷ÀÇ Á¦¾îµÈ ¹Ú¸® ¹× Åë°ú¸¦ °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á, Æ®¸³½ÅÀº ¼¼Æ÷ ¹è¾çÀÇ Áö¼ÓÀûÀÎ ¼ºÀå ¹× °ÇÀü¼ºÀ» º¸ÀåÇÕ´Ï´Ù. À̰ÍÀº ¹ÙÀÌ·¯½º¼º Áúȯ°ú °°Àº ¹é½Å°ú ´ÜŬ·ÐÇ×ü¸¦ Æ÷ÇÔÇÑ Ä¡·á ´Ü¹éÁúÀÇ ´ë·® »ý»ê¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¼¼°è Æ®¸³½Å ½ÃÀåÀº ¹ÙÀÌ¿À ÀǾàǰ ¼ö¿ä Áõ°¡¿Í °¡°ø ½ÄǰÀÇ ¼¼°è ¼ö¿ä Áõ°¡¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. Æ®¸³½ÅÀº ¼¼Æ÷ÁÖ¸¦ À¯Áö,È®´ëÇϱâ À§ÇÑ ¼¼Æ÷ ¹è¾çÀ̳ª Á¦Ç°ÀÇ Ç°Áú°ú Àϰü¼ºÀ» È®º¸Çϱâ À§ÇÑ ´Ü¹éÁú Á¤Á¦ µî ¹ÙÀÌ¿À ÀǾàǰÀÇ »ý»ê °øÁ¤¿¡ ÇʼöÀûÀÔ´Ï´Ù. »ý¸í°øÇÐÀÇ Çõ½Å°ú Á¦¾à ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â Æ®¸³½Å ½ÃÀåÀ» ´õ¿í ÃßÁøÇϰí ÀÖÀ¸¸ç, ÃֽŠġ·áÁ¦ °³¹ß¿¡ À־ Æ®¸³½ÅÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ºÎ°¢Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Æ®¸³½ÅÀº ´Ù¾çÇÑ ½ÄǰÀÇ ½Ä°¨°ú dz¹Ì¸¦ °³¼±ÇÏ°í ´Ü¹éÁúÀÌ Ç³ºÎÇÑ ½Äǰ ÷°¡¹°°ú º¸ÃæÁ¦¸¦ »ý»êÇÏ´Â ´Ü¹éÁúÀÇ °¡¼öºÐÇØ¿¡µµ »ç¿ëµË´Ï´Ù. ÀÌ È¿¼Ò´Â ´Ü¹éÁúÀ» ÆéŸÀ̵å¿Í ¾Æ¹Ì³ë»êÀ¸·Î ºÐÇØÇÏ´Â °ÍÀ» µ½°í °¡°ø ½ÄǰÀÇ ¿µ¾ç°¡¿Í ¼ÒÈ­¼ºÀ» ³ôÀÔ´Ï´Ù. ±×·¯³ª ÀǾàǰ Çã°¡¸¦ À§ÇÑ Æ¯Á¤ ¿ä°Ç°ú ¾Ë·¹¸£±â ¹ÝÀÀÀÇ À§ÇèÀº ¿¹Ãø ±â°£ 2024-2032³â ½ÃÀå Àüü ¼ö¿ä¸¦ ¹æÇØÇÒ °ÍÀÔ´Ï´Ù.

¼¼°è Æ®¸³½Å ½ÃÀå Á¶»ç¿¡¼­ °í·ÁÇÑ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ À¯·´ÀÔ´Ï´Ù. 2023³â ºÏ¹Ì´Â Áö¿ª Àüü¿¡¼­ ´ëÀå¾Ï Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Â µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼öÀ͸鿡¼­ °¡Àå ±Ô¸ð°¡ Å« Áö¿ª ½ÃÀåÀÌ µÇ¾ú½À´Ï´Ù. ´ÜŬ·ÐÇ×ü¿Í Ç¥Àû »ý¹°Á¦Á¦¸¦ Æ÷ÇÔÇÑ ¸¹Àº ´ëÀå¾Ï Ä¡·áÁ¦´Â ÀçÁ¶ÇÕ ´Ü¹éÁú ±â¼ú¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. Æ®¸³½ÅÀº À¶ÇÕ Å±׸¦ ºÐÇØÇϰí Ä¡·á¿ë ´Ü¹éÁúÀ» °í¼øµµ·Î ´Ü¸®ÇÔÀ¸·Î½á ´Ü¹éÁúÀÇ Á¤Á¦ °úÁ¤¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. °Ô´Ù°¡ ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº 2024³âºÎÅÍ 2032³â±îÁö ¿¹Ãø±â°£¿¡¼­ °¡Àå ºü¸¥ ¼Óµµ·Î ¹ßÀüÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡ Æ÷ÇÔµÈ ÁÖ¿ä ½ÃÀå ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

  • Novozymes A/S
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Promega Corporation
  • Bovogen Biologicals Pty Ltd
  • Zymetech ehf
  • BBI Solutions LLC
  • PromoCell GmbH
  • Ningbo Linzyme Biosciences Ltd

¸ñÂ÷

Á¦1Àå ¼¼°è Æ®¸³½Å ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ »çÇ×
    • °ø±ÞÃø ºÐ¼®
      • °¡¿ë¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ ½ÃÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼úÀÇ Áøº¸
      • ȯ°æ¿¡ÀÇ ¹è·Á
      • ¼ÒºñÀÚÀÇ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó³âµµ
  • ȯÀ² º¯È¯À²

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • Æ®¸³½Å ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022³â-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • °ø±Þ¿øº°
    • ¿ëµµº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±â ÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦3Àå ¼¼°è Æ®¸³½Å ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÇ °úÁ¦
  • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°è Æ®¸³½Å ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
    • Porter's Five Forces¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå Æ®¸³½Å ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : °ø±Þ¿øº°(2022³â-2032³â)

  • µÅÁö
  • ¼Ò
  • ±âŸ

Á¦6Àå Æ®¸³½Å ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°(2022³â-2032³â)

  • »ý¸í°øÇаú Á¦¾à»ê¾÷
  • ½Äǰ»ê¾÷
  • È­Àåǰ ¹× ÆÛ½º³ÎÄɾî
  • Æó±â¹° ó¸®
  • ±âŸ

Á¦7Àå Æ®¸³½Å ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2022³â-2032³â)

  • Á¶»ç¿ë
  • Áø´Ü¾à
  • »ê¾÷¿ë

Á¦8Àå Æ®¸³½Å ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°(2022³â-2032³â)

  • ºÏ¹ÌÀÇ Æ®¸³½Å ½ÃÀå
    • ¹Ì±¹
      • °ø±Þ¿øº°, ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø(2022³â-2032³â)
      • ¿ëµµº°, ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø(2022³â-2032³â)
      • ÃÖÁ¾ ¿ëµµº°, ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø(2022³â-2032³â)
    • ij³ª´ÙÀÇ Æ®¸³½Å ½ÃÀå
  • À¯·´ÀÇ Æ®¸³½Å ½ÃÀå
    • ¿µ±¹ÀÇ Æ®¸³½Å ½ÃÀå
    • µ¶ÀÏÀÇ Æ®¸³½Å ½ÃÀå
    • ÇÁ¶û½º Æ®¸³½Å ½ÃÀå
    • ½ºÆäÀÎÀÇ Æ®¸³½Å ½ÃÀå
    • ÀÌÅ»¸®¾ÆÀÇ Æ®¸³½Å ½ÃÀå
    • ±âŸ À¯·´ÀÇ Æ®¸³½Å ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Æ®¸³½Å ½ÃÀå
    • Áß±¹ÀÇ Æ®¸³½Å ½ÃÀå
    • ÀεµÀÇ Æ®¸³½Å ½ÃÀå
    • ÀϺ»ÀÇ Æ®¸³½Å ½ÃÀå
    • È£ÁÖÀÇ Æ®¸³½Å ½ÃÀå
    • Çѱ¹ÀÇ Æ®¸³½Å ½ÃÀå
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Æ®¸³½Å ½ÃÀå
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Æ®¸³½Å ½ÃÀå
    • ºê¶óÁúÀÇ Æ®¸³½Å ½ÃÀå
    • ¸ß½ÃÄÚÀÇ Æ®¸³½Å ½ÃÀå
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Æ®¸³½Å ½ÃÀå
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Æ®¸³½Å ½ÃÀå
    • »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ Æ®¸³½Å ½ÃÀå
    • ³²¾ÆÇÁ¸®Ä«ÀÇ Æ®¸³½Å ½ÃÀå
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Æ®¸³½Å ½ÃÀå

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Novozymes A/S
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ À̿밡´É¼º¿¡ µû¸§)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • Agilent Technologies Inc
    • Thermo Fisher Scientific Inc
    • Sartorius AG
    • Promega Corporation
    • Bovogen Biologicals Pty Ltd
    • Zymetech ehf
    • BBI Solutions LLC
    • PromoCell GmbH
    • Ningbo Linzyme Biosciences Ltd

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
BJH 24.07.12

Global Trypsin Market is valued at approximately USD 91.6 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.92% over the forecast period 2024-2032. Trypsin is a digestive enzyme produced in the pancreas that breaks down proteins into smaller peptides within the small intestine. It is secreted as the inactive precursor trypsinogen, which is activated by enter peptidase. These digestive enzyme plays a crucial role in nutrient absorption and regulate other digestive enzymes by converting them from their inactive forms to active states, ensuring efficient digestion. Additionally, the rising focus on advanced therapeutics are gaining attention in the Global Trypsin Market. Trypsin is crucial in cell culture processes to dissociate adherent cells from the surface of culture vessels. This step is essential for subculturing, which maintains and expands cell lines used in producing vaccines and therapeutic proteins. By enabling the controlled detachment and passage of cells, trypsin ensures the continuous growth and health of cell cultures. This is vital for large-scale production of vaccines, such as those for viral diseases, and therapeutic proteins, including monoclonal antibodies.

The Global Trypsin Market is driven by increasing demand for biopharmaceuticals and growing demand for processed foods across the world. Trypsin is essential in biopharmaceutical production processes, such as cell culture for maintaining and expanding cell lines, and protein purification for ensuring product quality and consistency. Innovations in biotechnology and increased investments in pharmaceutical research further propel the trypsin market, highlighting its critical role in developing modern therapeutics. In addition, trypsin is used to improve the texture and flavor of various food products, as well as in protein hydrolysis to produce protein-rich food additives and supplements. The enzyme aids in breaking down proteins into peptides and amino acids, enhancing the nutritional value and digestibility of processed foods. However, specific requirements for drug approvals and risk of allergic reactions are going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Trypsin market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue owing to factors such as increasing focus on therapeutics solutions for colorectal cancer across the region. Many colorectal cancer therapies, including monoclonal antibodies and targeted biologics, rely on recombinant protein technology. Trypsin plays a crucial role in protein purification processes by breaking down fusion tags and facilitating the isolation of therapeutic proteins with high purity. Furthermore, the market in Asia Pacific is expected to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:

  • Novozymes A/S
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Promega Corporation
  • Bovogen Biologicals Pty Ltd
  • Zymetech ehf
  • BBI Solutions LLC
  • PromoCell GmbH
  • Ningbo Linzyme Biosciences Ltd

The detailed segments and sub-segment of the market are explained below:

By Source

  • Porcine
  • Bovine
  • Others

By Application

  • Biotechnology and Pharmaceutical Industry
  • Food Industry
  • Cosmetics and Personal Care
  • Waste Treatment
  • Others

By End-use

  • Research
  • Diagnostics
  • Industrial use

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Trypsin Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Trypsin Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Source
    • 2.3.2. By Application
    • 2.3.3. By End-use
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Trypsin Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Trypsin Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Trypsin Market Size & Forecasts by Source 2022-2032

  • 5.1. Porcine
  • 5.2. Bovine
  • 5.3. Others

Chapter 6. Global Trypsin Market Size & Forecasts by Application 2022-2032

  • 6.1. Biotechnology and Pharmaceutical Industry
  • 6.2. Food Industry
  • 6.3. Cosmetics and Personal Care
  • 6.4. Waste Treatment
  • 6.5. Others

Chapter 7. Global Trypsin Market Size & Forecasts by End-use 2022-2032

  • 7.1. Research
  • 7.2. Diagnostics
  • 7.3. Industrial use

Chapter 8. Global Trypsin Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Trypsin Market
    • 8.1.1. U.S. Trypsin Market
      • 8.1.1.1. Source breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.1.1.3. End-use breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Trypsin Market
  • 8.2. Europe Trypsin Market
    • 8.2.1. U.K. Trypsin Market
    • 8.2.2. Germany Trypsin Market
    • 8.2.3. France Trypsin Market
    • 8.2.4. Spain Trypsin Market
    • 8.2.5. Italy Trypsin Market
    • 8.2.6. Rest of Europe Trypsin Market
  • 8.3. Asia-Pacific Trypsin Market
    • 8.3.1. China Trypsin Market
    • 8.3.2. India Trypsin Market
    • 8.3.3. Japan Trypsin Market
    • 8.3.4. Australia Trypsin Market
    • 8.3.5. South Korea Trypsin Market
    • 8.3.6. Rest of Asia Pacific Trypsin Market
  • 8.4. Latin America Trypsin Market
    • 8.4.1. Brazil Trypsin Market
    • 8.4.2. Mexico Trypsin Market
    • 8.4.3. Rest of Latin America Trypsin Market
  • 8.5. Middle East & Africa Trypsin Market
    • 8.5.1. Saudi Arabia Trypsin Market
    • 8.5.2. South Africa Trypsin Market
    • 8.5.3. Rest of Middle East & Africa Trypsin Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Novozymes A/S
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Agilent Technologies Inc
    • 9.3.3. Thermo Fisher Scientific Inc
    • 9.3.4. Sartorius AG
    • 9.3.5. Promega Corporation
    • 9.3.6. Bovogen Biologicals Pty Ltd
    • 9.3.7. Zymetech ehf
    • 9.3.8. BBI Solutions LLC
    • 9.3.9. PromoCell GmbH
    • 9.3.10. Ningbo Linzyme Biosciences Ltd

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦